Effectiveness of Mindfulness-Based Cognitive Therapy in reducing psychological distress and improving sleep in patients with Inflammatory Bowel Disease: study protocol for a multicentre randomised controlled trial (MindIBD).

Milou M. ter Avest*, Annelieke S.M. van Velthoven, Anne E.M. Speckens, Gerard Dijkstra, Martin Dresler, Carmen S. Horjus, Tessa E.H. Römkens, Ellen M. Witteman, Willemijn A. van Dop, Quirine M. Bredero, Loes H.C. Nissen, Marloes J. Huijbers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Downloads (Pure)


Background: Many patients with Inflammatory Bowel Diseases (IBD) suffer from psychological distress, fatigue and sleep disturbances, which are associated with reduced quality of life (QoL) and increased societal costs. Only limited psychosocial treatment options are available. As Mindfulness-Based Cognitive Therapy (MBCT) has demonstrated to improve psychological distress, QoL and sleep in other populations, MBCT might also be effective in patients with IBD. Methods: The MindIBD study is a prospective, multicentre, randomised controlled trial comparing MBCT plus Treatment As Usual (TAU) versus TAU alone in a targeted number of 136 IBD patients in remission, aged 16 years and older with at least mild psychological distress (Hospital Anxiety and Depression Scale (HADS) total score ≥ 11). Primary outcome is reduction of psychological distress post-intervention, measured by the HADS. In addition, the effect of MBCT on sleep quality (including actigraphy and electroencephalography recordings), fatigue, disease activity, perceived disease control, QoL and positive mental health will be examined. Assessments will be conducted at baseline and at 3, 6, 9 and 12 months follow-up. Cost-effectiveness will be determined and a process evaluation will be conducted. Discussion: This study will provide valuable insight into the clinical effect of MBCT on psychological distress, sleep quality, fatigue and QoL in IBD patients and into the cost-effectiveness. If effective, MBCT can be a valuable addition to the available psychosocial interventions for patients with IBD. Moreover, findings from this study may also be applicable in patients with other chronic conditions. Trial registration: ClinicalTrials.gov: NCT04646785, registered on 30/11/2020.

Original languageEnglish
Article number183
Number of pages12
JournalBMC Psychology
Publication statusE-pub ahead of print - 19-Jun-2023


  • (Cost-)effectiveness
  • Crohn’s disease
  • Inflammatory Bowel Disease
  • Mindfulness
  • Mindfulness-Based Cognitive Therapy
  • Psychological distress
  • Randomised controlled trial
  • Sleep quality
  • Study protocol
  • Ulcerative colitis

Cite this